Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation

Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation

Mahfoozur Rahman,1 Waleed H Almalki,2 Obaid Afzal,3 Abdulmalik Saleh Alfawaz Altamimi,3 Imran Kazmi,4 Fahad A Al-Abbasi,4 Hani Choudhry,5 Sattam K Alenezi,6 Md Abul Barkat,7 Sarwar Beg,8 Vikas Kumar,1 Abdulsalam Alhalmi9 1Department of Pharmaceutical Sciences, Shalom Institute of Health & Al...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rahman M, Almalki WH, Afzal O, Alfawaz Altamimi AS, Kazmi I, Al-Abbasi FA, Choudhry H, Alenezi SK, Barkat MA, Beg S, Kumar V, Alhalmi A
Format: article
Langue:EN
Publié: Dove Medical Press 2020
Sujets:
resveratrol
cationic solid lipid
solid lipid nanoparticles
inflammatory biomarkers
hepatocellular carcinoma
diethyl nitrosamine
Medicine (General)
R5-920
Accès en ligne:https://doaj.org/article/44aaf762688340f7a5c739aba36fc390
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/44aaf762688340f7a5c739aba36fc390

Documents similaires